To wrap up the year, let’s sit down again with 13 leaders of Big Law litigation practices and elite boutiques we connected with in 2025 for our Litigation Leaders series. A Winston & Strawn team led ...

This roundtable discussion is produced by the LA Times Studios team in conjunction with Benesch; D.Law; and Parker Shaffie LLP. After the many unprecedented operational changes that businesses in ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Standing out among Canada’s sought-after top litigation law firms requires a blend of creativity, courage, and commercial savvy – not to mention advocacy skills, legal expertise, and an unmatched ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed ...

LONDON, Dec 22 (Reuters) - Hedge funds last week sold more U.S. healthcare stocks than they bought for the first time in 14 weeks, Goldman Sachs (GS.N), opens new tab said in a note on Friday, as ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...